{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": -0.09990179, "regularMarketPrice": 0.4, "exchange": "NCM", "shortName": "Vaccinex, Inc.", "longName": "Vaccinex, Inc.", "messageBoardId": "finmb_11044719", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "firstTradeDateMilliseconds": 1533821400000, "priceHint": 4, "earningsTimestampEnd": 1692361800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.46, "epsForward": -0.14, "sharesOutstanding": 49880900, "bookValue": 0.104, "fiftyDayAverage": 0.403, "fiftyDayAverageChange": -0.0029999912, "fiftyDayAverageChangePercent": -0.007444147, "twoHundredDayAverage": 0.60025, "twoHundredDayAverageChange": -0.20025, "twoHundredDayAverageChangePercent": -0.33361098, "marketCap": 21942560, "forwardPE": -2.857143, "priceToBook": 3.8461537, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.00040000677, "regularMarketTime": 1684180675, "regularMarketDayHigh": 0.42, "regularMarketDayRange": "0.3952 - 0.42", "regularMarketDayLow": 0.3952, "regularMarketVolume": 65249, "regularMarketPreviousClose": 0.4004, "bid": 0.0, "ask": 0.0, "bidSize": 8, "askSize": 9, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 0.4, "averageDailyVolume3Month": 99676, "averageDailyVolume10Day": 118960, "fiftyTwoWeekLowChange": 0.060000002, "fiftyTwoWeekLowChangePercent": 0.1764706, "fiftyTwoWeekRange": "0.34 - 1.5", "fiftyTwoWeekHighChange": -1.1, "fiftyTwoWeekHighChangePercent": -0.73333335, "fiftyTwoWeekLow": 0.34, "fiftyTwoWeekHigh": 1.5, "earningsTimestamp": 1684183500, "earningsTimestampStart": 1692016200, "displayName": "Vaccinex", "symbol": "VCNX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1895 Mount Hope Avenue", "city": "Rochester", "state": "NY", "zip": "14620", "country": "United States", "phone": "585 271 2700", "fax": "585 271 2765", "website": "https://www.vaccinex.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D. Its Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. It has also developed ActivMAb, an antibody drug discovery platform based on a novel method for complex targets, such as multi-pass membrane receptors or large and diverse libraries of full-length human monoclonal antibodies on the surface of pox viruses. The company was incorporated in 2001 and is headquartered in Rochester, New York.", "fullTimeEmployees": 38, "companyOfficers": [{"maxAge": 1, "name": "Dr. Maurice  Zauderer Ph.D.", "age": 76, "title": "Co-Founder, CEO, Pres & Director", "yearBorn": 1946, "fiscalYear": 2022, "totalPay": {"raw": 400700, "fmt": "400.7k", "longFmt": "400,700"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Elizabeth E. Evans Ph.D.", "age": 50, "title": "COO and Sr. VP of Discovery & Translational Medicine", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 255455, "fmt": "255.46k", "longFmt": "255,455"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ernest S. Smith Ph.D.", "age": 50, "title": "Sr. VP of Research & Chief Scientific Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 284021, "fmt": "284.02k", "longFmt": "284,021"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Scott E. Royer C.F.A., M.B.A.", "age": 48, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. John E. Leonard Ph.D.", "age": 75, "title": "Sr. VP of Devel.", "yearBorn": 1947, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}